semaglutide weight loss papillion GLP-1 Injections Scale Down Weight Loss Clinic

Their filing for FDA approval of CagriSema in early 2026 puts them on track for a potential approval decision by late 2026 or early 2027

Treating BED is not just about medicationfactors like biology, emotional eating, nutrition, and co-existing mental health conditions like depression, anxiety, substance use disorder, and obsessive-compulsive disorder (OCD) may cause binge eating disorder

Register today for our series of live webinars on GLP-1s, their role in treating cardiometabolic diseases, and strategies for managing GLP-1 treatments in your healthcare plan

Optimize detoxification, immune function, and longevity

General guidance includes: Stay at your current dose longer before increasing

An addiction can interfere with many areas of a persons life, such as their health, relationships, schoolwork, and employment